Vimarsana
Biggest News Aggregation in the World

Lee Buckler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lee Buckler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lee Buckler Today - Breaking & Trending Today

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -November 30, 2023 at 01:09 pm EST - Vimarsana News

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -November 30, 2023 at 01:09 pm EST

Published: November 30, 2023

REPLICEL LIFE SCIENCES INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the six months ended September 30, 2023 and 2022 ...

Source: marketscreener.com
Related Topics:
United StatesBritish ColumbiaHong KongLee BucklerDavid HallReplicel Life Sciences IncCompany Stock Option PlanCompany Or ReplicelInternational Financial Reporting StandardsShiseido CompanyCompany OptionsVenture ExchangeParty TransactionsBus PartnershipTrichoscience Innovations IncInternational Accounting Standards BoardMainpointe PharmaceuticalsTechnology Transfer AgreementChina Health Industry CoWhile The CompanyNational InstrumentGiven The CompanyCanadian DollarsInterim FinancialConsolidated Interim Statements
Altius Bioventures Initiates Fundraising for Altius Bioventures Fund ... - Vimarsana News

Altius Bioventures Initiates Fundraising for Altius Bioventures Fund ...

Published: November 15, 2023

Altius Bioventures Initiates Fundraising for Altius Bioventures Fund ...

Source: pr-inside.com
Related Topics:
British ColumbiaEmmanuel GrillotLee BucklerTroels JordansenAltius BioventuresRakesh VermaNews NetworkAltius Bioventures FundAltius Bioventures RacerManaging DirectorBlair Jordan
REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -October 24, 2023 at 11:14 am EDT - Vimarsana News

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -October 24, 2023 at 11:14 am EDT

Published: October 24, 2023

REPLICEL LIFE SCIENCES INC. CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the six months ended June 30, 2023 and 2022 ...

Source: marketscreener.com
Related Topics:
British ColumbiaHong KongUnited StatesLee BucklerDavid HallParty TransactionsBus PartnershipVenture ExchangeTrichoscience Innovations IncInternational Financial Reporting StandardsCompany OptionsShiseido CompanyChina Health Industry CoReplicel Life Sciences IncMainpointe PharmaceuticalsInternational Accounting Standards BoardCompany Stock Option PlanTechnology Transfer AgreementWhile The CompanyCompany Or ReplicelNational InstrumentGiven The CompanyCanadian DollarsInterim FinancialConsolidated Interim Statements
REPLICEL LIFE SCIENCES : STATEMENT OF EXECUTIVE COMPENSATION - Vimarsana News

REPLICEL LIFE SCIENCES : STATEMENT OF EXECUTIVE COMPENSATION

Published: August 10, 2023

REPLICEL LIFE SCIENCES INC. STATEMENT OF EXECUTIVE COMPENSATION Form 51-102F6V Statement of... -Today at 06:06 am- MarketScreener

Source: marketscreener.com
Related Topics:
Peter LewisGary BoddingtonAndrew SchutteDavid HallKevin McelweeRolf HoffmanPeter LowryRolf HoffmannLee BucklerR Lee BucklerSimon MaBen AustringCompany InformationManagement Company EmployeeTrichoscience Innovations IncCompany OnConsultant CompanyGiven The CompanyInvestor Relations Service ProvidersEligible Charitable Organizations Of The CompanyCompensation ProgramAudit CommitteeVenture ExchangeReplicel Life Sciences IncAdministration Of The Plan
RepliCel Life Sciences : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K - Vimarsana News

RepliCel Life Sciences : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K

Published: May 31, 2023

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS For the three months ended March 31, 2023 and 2022 Notice of No Auditor... | May 31, 2023

Source: marketscreener.com
Related Topics:
United StatesHong KongBritish ColumbiaLee BucklerDavid HallWhile The CompanyMainpointe PharmaceuticalsTechnology Transfer AgreementGiven The CompanyCompany Stock Option PlanCompany Or ReplicelInternational Accounting Standards BoardShare Of The CompanyReplicel Life Sciences IncVenture Exchange TheVenture ExchangeParty TransactionsShiseido CompanyBus PartnershipInternational Financial Reporting StandardsCompany OptionsChina Health Industry CoNational InstrumentTrichoscience Innovations IncCanadian Dollars